ArticleEuropean journal of pain (London, England)2026
Early Pain and Sensory Dysfunction in Drug-Naïve Parkinson's Disease: Evidence From Quantitative Sensory Testing.
Article in European journal of pain (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPain and sensory disturbances are common non-motor symptoms in Parkinson's disease (PD) and can occur early in the disease course, even before starting dopaminergic treatment. However, somatosensory abnormalities in drug-naïve PD remain insufficiently characterized, particularly in the absence of dopaminergic medication effects.
methodsIn this cross-sectional study, 35 people with drug-naïve PD (PwP) and 35 individually age- and sex-matched healthy controls underwent quantitative sensory testing (QST). Testing included brush stimulation to assess dynamic mechanical allodynia (DMA), pinprick stimulation to assess mechanical pain sensitivity-both rated using a numeric rating scale (NRS)-and pressure pain threshold (PPT) measurements. PwP were stratified by daily pain status. Data were analysed using linear mixed-effects models (LMEMs) that accounted for matching and repeated measures.
resultsPinprick stimulation revealed statistically significant mechanical hyperalgesia across all tested body regions in PwP, regardless of pain status, compared with healthy controls. PPT testing demonstrated significantly lower thresholds in PwP across most body regions, indicating early pressure hyperalgesia. In contrast, brush testing did not reveal significant group differences, and only a small proportion of PwP showed signs of DMA. No significant differences were observed between PwP with and without pain, nor between the disease-onset side and the contralateral side.
conclusionsDrug-naïve PD is characterized by early nociceptive sensory abnormalities, with consistent evidence of mechanical hyperalgesia even in patients without chronic pain. The absence of DMA suggests that nociceptive hypersensitivity may precede alterations in non-nociceptive processing. Nociceptive QST measures may therefore represent indicators of altered sensory processing in early-stage PwP. SIGNIFICANCE STATEMENT: This study adds to existing evidence that sensory disturbances, including pain, may be present already in the early, drug-naïve stages of Parkinson's disease. Clinically, these findings highlight the importance of recognizing pain and sensory abnormalities as potential early non-motor features of PD, including before dopaminergic treatment is initiated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.